JPRN-UMIN000011788已完成未知
The efficacy of DPP-4 inhibitors and alpha glucosidase inhibitors for type 2diabetes - The efficacy of DPP-4 inhibitors and alpha glucosidase inhibitors for type 2diabetes
ational Center for Global Health and Medicine0 个研究点目标入组 15 人开始时间: 2013年9月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with severe liver dysfunction or renal dysfunction.
研究者
相似试验
已完成
不适用
Effect of a DPP-4 inhibitor or an alpha-glucosidase inhibitor on endothelial function in patients with type 2 diabetesType 2 diabetic patientsJPRN-UMIN000003951Cardiovascular Dysfunction Study group50
已完成
不适用
Effect of DPP4 inhibitor or alpha-glucosidase inhibitor on postprandial lipemia and endothelial dysfunctioJPRN-UMIN000012738Okayama Rosai Hospital10
招募中
不适用
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000011864Tokyo Women's Medical University100
已完成
不适用
Examination of the usefulness of DPP-4 inhibitor in the treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000011862aka Kinen Clinic10
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128